Check out this video with Ludwig @ox.ac.uk’s Xin Lu on the @cancergrand.bsky.social Team ATLAS’s goal to find biomarkers—antibody fingerprints—that predict whether someone might avoid or, conversely, develop cancer and possibly identify treatments for cancer prevention or therapy.
bit.ly/3RrNtZM
bit.ly
One of the biggest challenges in cancer research is effective cancer prevention. The ATLAS team is exploring how the body’s natural defences may help prevent cancer from developing in the first place. By studying people who avoid cancer despite age, genetics or lifestyle risk factors, researchers hope to uncover what makes these ‘cancer avoiders’ different. The team believes antibodies could hold an important part of the answer. Learn more about ATLAS and follow the team’s progress ➡️ https://www.cancergrandchallenges.org/atlas ATLAS is funded by @CancerResearchUK and the Torrey Coast Foundation through Cancer Grand Challenges. Team Leadership: Paul Bastard – Institute IMAGINE, France Co-Investigators: Jean-Laurent Casanova – UT Southwestern Medical Center, US. Jacques Fellay – EPFL & Lausanne University Hospital, Switzerland. Tyler Hulett – CDI Laboratories, US. Trine Hyrup Mogensen – Aarhus University, Denmark. Nils Landegren – Uppsala University, Sweden. Xin Lu – Ludwig Institute for Cancer Research, University of Oxford, UK. Ruth Travis – Oxford Population Health, University of Oxford, UK. Chi Van Dang – Ludwig Cancer Research, US. Patient Advocates: Sue Friedman – US. Karl Smith-Byrne – UK. Cancer Grand Challenges is a global research initiative, co-founded by Cancer Research UK and the National Cancer Institute in the US, that brings together world-class interdisciplinary teams to tackle some of cancer’s toughest challenges, with more than £465 million invested to date. Subscribe: https://www.youtube.com/@CancerGrandChallenges LinkedIn: https://www.linkedin.com/company/cancergrandchallenges/ X: https://x.com/home Bluesky: https://bsky.app/profile/cancergrand.bsky.social Website: https://www.cancergrandchallenges.org/
